DSD-C126
Congenital adrenal hyperplasia · 46,XX · DSD-C126
46,XX disorder of sex development — aromatase deficiency (AD). Often misdiagnosed as CAH 21-OHD. AD features: non-progressive external virilization + maternal androgen excess + delayed bone age + hypergonadotropism.
Images · 2
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia
- Age
-
2 years 8 months (first evaluated at 6 months)
- Sex
-
46,XX, raised as female
- Karyotype
-
46,XX
- Genetics
-
CYP19A1
- Diagnosis
-
46,XX disorder of sex development — aromatase deficiency (AD). Often misdiagnosed as CAH 21-OHD. AD features: non-progressive external virilization + maternal androgen excess + delayed bone age + hypergonadotropism.
- Follow-up
-
Annual clinical evaluation follow-up. Future risks: insulin resistance, dyslipidemia, metabolic syndrome. Estrogen replacement at puberty induction.
- General phenotype
-
Non-palpable gonads; general examination normal.
- Imaging
-
Hand/wrist X-ray showed delayed bone age (16 mo vs actual 28 mo); pelvic ultrasound showed infantile uterus, small ovaries without follicles; Genitogram with low-position vaginal confluence.
- Laboratory findings
-
Karyotype: 46,XX (reference: –; time point: initial visit); FISH(SRY): negative (reference: negative; time point: both negative); 17-OHP (baseline): 2.46 ng/mL (reference: ≤1.47; time point: 6 months); 17-OHP (post-stimulation): 4.2 ng/mL (reference: <10; time point: post-tetracosactide); serum cortisol (baseline): 10.3 μg/dL (reference: 1.4–27; time point: 08:00); ACTH (baseline): 13.2 pg/mL (reference: <46; time point: frozen sample); DHEAS: 15 μg/dL (reference: <74; time point: 6 months); total testosterone (fasting): 5.47 ng/mL (reference: 2–5; time point: 08:00 fasting); FSH: 67.67/90.42 mIU/mL (reference: 0.7–3.4; time point: markedly elevated, postmenopausal level); LH: 3.06/1.8 mIU/mL (reference: ≤0.26; time point: above normal preschool values); AMH: 0.13/0.05 ng/mL (reference: <0.01; time point: very low); bone age (X-ray): 16 months (reference: actual 28 months, delayed; time point: at 2y8m); testosterone on day 5 of hCG stimulation: 14.64 ng/mL (reference: >2-fold rise = functional Leydig cells; time point: hCG stimulation); pelvic ultrasound: infantile uterus, gonads not visualized (reference: –; time point: 6 months); repeat pelvic ultrasound: uterus 1.7×0.5×0.8 cm, ovaries 5×4 mm/5×3 mm without follicles (reference: atrophic ovaries; time point: 3 years)
- Management
-
Parents chose to continue female rearing. Regular follow-up, plan to induce puberty at ~10–12 years (estrogen replacement). Low-dose estrogen withheld for now (no ovarian cysts).
- Pathology
-
Gonadal pathology not reported.
- Evidence level
-
See source
- Clinical history
-
See source
- Perinatal history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- External genital examination
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia · 46,XX · DSD-C126 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C126?version=v1.4.0